| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/06/2012 | WO2012165616A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION |
| 12/06/2012 | WO2012165407A1 Method for screening for therapeutic agent for cartilage diseases, and genetically modified cartilage cell for use in treatment of cartilage diseases |
| 12/06/2012 | WO2012165175A1 Transgenic non-human animal model of neurodegenerative disease |
| 12/06/2012 | WO2012164936A1 Suv39h2 as a target gene for cancer therapy and diagnosis |
| 12/06/2012 | WO2012164736A1 Method for distinguishing chronic inflammation such as inflammatory bowel disease |
| 12/06/2012 | WO2012164552A1 Microfluidic disc for use in with bead-based immunoassays |
| 12/06/2012 | WO2012164537A1 Air flow temperature and humidity sensor device for use in a motor vehicle |
| 12/06/2012 | WO2012164525A2 Aging biomarkers |
| 12/06/2012 | WO2012164350A2 Apparatus and method for characterizing parameters for the cracking, in-situ combustion, and upgrading of hydrocarbons |
| 12/06/2012 | WO2012164270A1 Coupling method |
| 12/06/2012 | WO2012164268A1 Optical glucose biosensor calibration using different temperature calibration solutions |
| 12/06/2012 | WO2012164263A1 Capillary fluid flow measurment and capillary flow device therefore |
| 12/06/2012 | WO2012164221A1 Method for detecting and quantifying a target molecule in a tissue |
| 12/06/2012 | WO2012164136A1 TGF-β AND/OR SMAD3 AS MARKERS FOR THE DIAGNOSIS AND/OR PROGNOSIS OF α-SYNUCLEINOPATHIES |
| 12/06/2012 | WO2012164088A1 Diagnosis method of active tuberculosis |
| 12/06/2012 | WO2012164035A1 Method for predicting the risk of developing a colonic neoplasia |
| 12/06/2012 | WO2012164026A1 Methods for diagnosing multiple sclerosis |
| 12/06/2012 | WO2012164008A1 Method of evaluation of the effect of nanoparticles on cell cultures |
| 12/06/2012 | WO2012163807A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection |
| 12/06/2012 | WO2012163768A1 Detection of diagnostic peptides |
| 12/06/2012 | WO2012163640A1 System and method of controlling dosing of a disinfectant into water |
| 12/06/2012 | WO2012163361A1 Method and system for identification of physiological imbalance in an animal |
| 12/06/2012 | WO2012163286A1 Method and kit for detecting hepcidin |
| 12/06/2012 | WO2012162869A1 Inductive wear particle monitoring device and detecting unit thereof |
| 12/06/2012 | WO2012162820A1 Maleimide-functionalized gold nanoparticles |
| 12/06/2012 | WO2012162807A1 Brain tumor targeting peptides and methods |
| 12/06/2012 | WO2012162779A1 Microfluidic cell trap and assay apparatus for high-throughput analysis |
| 12/06/2012 | WO2012162741A1 Enrichment of cardiomyocytes |
| 12/06/2012 | WO2012162732A1 Assays for sodium ion channel modulators and uses thereof |
| 12/06/2012 | WO2012142349A3 Gene expression profile for therapeutic response to vegf inhibitors |
| 12/06/2012 | WO2012142159A3 Structural mutations in titin cause dilated cardiomyopathy |
| 12/06/2012 | WO2012139002A3 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer |
| 12/06/2012 | WO2012135227A3 Methods and systems for assessing exposure to heavy metals |
| 12/06/2012 | WO2012135208A3 Use of low global warming potential (lgwp) solvents for finger print development applications |
| 12/06/2012 | WO2012134074A3 Optical sensor strip and diagnostic device comprising same |
| 12/06/2012 | WO2012129452A8 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
| 12/06/2012 | WO2012129341A3 Disease detection in plants |
| 12/06/2012 | WO2012128841A3 Micro-devices for disease detection |
| 12/06/2012 | WO2012125781A3 Rapid detection of pathogens using paper devices |
| 12/06/2012 | WO2012125721A9 Methods and materials for using the contents of phagocytes to detect neoplasms |
| 12/06/2012 | WO2012120315A3 Mutant proteins and methods for producing them |
| 12/06/2012 | WO2012118800A3 Enhancing endotoxin detection |
| 12/06/2012 | WO2012112013A3 A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer |
| 12/06/2012 | WO2012109617A3 Method of assaying dna topoisomerases and dna binding proteins using high throughput screening |
| 12/06/2012 | WO2012102545A3 Cell cycle measuring method based on an electrochemical method |
| 12/06/2012 | WO2012100070A3 Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease |
| 12/06/2012 | WO2012099365A3 Breath alcohol analyzer |
| 12/06/2012 | WO2012099364A3 Kit for amplifying detected signal in immunosensor and method for detecting target antigen using the same |
| 12/06/2012 | WO2012096480A3 Diagnostic cartridge and control method for diagnostic cartridge |
| 12/06/2012 | WO2012092376A3 Comprehensive monoclonal antibody generation |
| 12/06/2012 | WO2012078602A3 Method for diagnosis and method of treatment of autism spectrum disorders and intellectual disability |
| 12/06/2012 | WO2012068243A3 Methods for obtaining target cells |
| 12/06/2012 | WO2012067970A3 Transcriptional repression leading to parkinson's disease |
| 12/06/2012 | WO2012040602A3 Targeting mtor substrates in treating proliferative diseases |
| 12/06/2012 | WO2012037560A3 Semi-automated heat exchanger tube cleaning assembly and method |
| 12/06/2012 | WO2012003330A3 Multiplexed identification of nucleic acid sequences |
| 12/06/2012 | WO2011147563A8 Method for electrochemically detecting binding reactions |
| 12/06/2012 | WO2011107076A8 Use of halogenated cyanocinnamic acid derivatives as matrices in maldi mass spectrometry |
| 12/06/2012 | WO2011072065A8 Microbially-based sensors for environmental monitoring |
| 12/06/2012 | WO2009038536A8 A device, system and method for washing and isolating magnetic particles in a continuous fluid flow |
| 12/06/2012 | US20120311729 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Atherosclerosis |
| 12/06/2012 | US20120310586 Container control |
| 12/06/2012 | US20120310108 Computer-implemented integrated health systems and methods |
| 12/06/2012 | US20120310056 Peritoneal dialysis system |
| 12/06/2012 | US20120309951 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis |
| 12/06/2012 | US20120309943 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier |
| 12/06/2012 | US20120309936 Reducing the immunogenicity of fusion proteins |
| 12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/06/2012 | US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 12/06/2012 | US20120309778 Fused and Spirocycle Compounds and the Use Thereof |
| 12/06/2012 | US20120309704 Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias |
| 12/06/2012 | US20120309697 Methods of diagnosing and prognosing colonic polyps |
| 12/06/2012 | US20120309677 Methods for regulating blood glucose levels |
| 12/06/2012 | US20120309671 Process for the measurement of the potency of glatiramer acetate |
| 12/06/2012 | US20120309643 Method and/or apparatus of oligonucleotide design and/or nucleic acid detection |
| 12/06/2012 | US20120309640 Diagnostic and Prognostic Markers for Cancer |
| 12/06/2012 | US20120309111 Biosample plate with data storage and wireless communication means |
| 12/06/2012 | US20120309110 Diagnostic agent for urinary protein of cat |
| 12/06/2012 | US20120309109 Method for determining the binding constant of high affinity compounds |
| 12/06/2012 | US20120309106 Detection of a target in a sample |
| 12/06/2012 | US20120309103 Method for measuring luminescence at a luminescence detection workstation |
| 12/06/2012 | US20120309100 Sample preparation for isotopic analysis without an oxidizer |
| 12/06/2012 | US20120309098 Method for predicting the amounts of biogenic gas generated by biological conversion of organic matter |
| 12/06/2012 | US20120309041 Determination of Exosomel Biomarkers for Predicting Cardiovascular Events |
| 12/06/2012 | US20120309035 Stable solution |
| 12/06/2012 | US20120309034 METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME |
| 12/06/2012 | US20120309032 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection |
| 12/06/2012 | US20120309031 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 12/06/2012 | US20120309029 Methods for diagnosis, prognosis and methods of treatment |
| 12/06/2012 | US20120309028 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
| 12/06/2012 | US20120309026 Methods and compositions for detecting the activation state of multiple proteins in single cells |
| 12/06/2012 | US20120309024 Electrophoretically Enhanced Detection of Analytes on a Solid Support |
| 12/06/2012 | US20120309023 Dual activity kinase domains and uses thereof |
| 12/06/2012 | US20120309021 Detection of antibody that binds to water soluble polymer-modified polypeptides |
| 12/06/2012 | US20120309020 Lysyl oxidase-like 2 assay and methods of use thereof |
| 12/06/2012 | US20120309019 Detection of unhealthy bone marrow-derived cell for disease predispositions |
| 12/06/2012 | US20120309018 Cancer detection markers |
| 12/06/2012 | US20120309017 Perinucleolar compartment as a cancer marker |
| 12/06/2012 | US20120309016 3d adcc nk facs assay |
| 12/06/2012 | US20120309015 Methods and compositions for detecting endometrial or ovarian cancer |